cancer pain

Promising Signals Emerge from Two Phase II Cancer Studies
BioSpace
Mon, 11/29/21 - 11:10 pm
clinical trials
cancer
Tetra Bio-Pharma
cancer pain
Starpharma
cabazitaxel
prostate cancer
Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial
Xtalks
Thu, 07/6/17 - 09:39 am
Sorrento Therapeutics
clinical trials
FDA
cancer pain
Resiniferatoxin
2015's Worst Clinical Failures
Motley Fool
Sat, 12/12/15 - 02:01 pm
clinical trials
liver disease
cancer pain
Eli Lilly
Intercept Pharmaceuticals
GW Pharma
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
Bizjournals.com
Thu, 08/13/15 - 02:47 pm
FDA
BioDelivery Sciences
Onsolis
cancer pain
breakthrough pain
BioDelivery Sciences to relaunch cancer pain medication; shares bounce
Bizjournals.com
Wed, 01/28/15 - 08:21 am
BioDelivery Sciences
Onsolis
Meda
cancer pain
GW Cannabinoid Drug Fails Cancer Pain Trial
24/7 Wall St
Thu, 01/8/15 - 02:42 pm
GW Pharma
cannabis
cancer pain
Sativex
Forget The Sideshow Distractions And Focus On Galena's Pipeline
Seeking Alpha
Tue, 03/4/14 - 08:44 am
Galena Biopharma
Abstral
NeuVax
cancer pain
breast cancer
Breaking Down Abstral Sales For Galena Biopharma
Seeking Alpha
Sun, 02/23/14 - 11:20 am
Galena Biopharma
Abstral
cancer pain
pain management
Galena Biopharma: David Battles Goliath
Seeking Alpha
Wed, 06/19/13 - 03:47 pm
Galena Biopharma
breast cancer
Teva
cancer pain
Orexo
Galena pays $10M upfront to license Abstral, a treatment for severe episodes of cancer pain
Yahoo/AP
Mon, 03/18/13 - 11:09 am
Galena Biopharma
Abstral
cancer pain
Orexo
Pot-based prescription drug looks for FDA OK
Yahoo/AP
Mon, 01/23/12 - 09:48 am
marijuana
FDA
GW Pharma
cancer pain
Impax Sued by Teva’s Cephalon Over Fentora Pain Drug Patents
Bloomberg
Mon, 11/21/11 - 11:39 am
Impax
Teva Pharmaceuticals
Cephalon
Fentroa
cancer pain
Cephalon Gets More Competition
Yahoo/Zacks.com
Wed, 07/22/09 - 03:01 pm
Cephalon
BioDelivery Sciences
Onsolis
cancer pain